Genovefa Papanicolaou is an Infectious Disease physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 286 publications with 11,581 citations (h-index 51); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1275 York Ave
New York, NY 100216007
Telephone
212-639-2000Registry record last updated 7 Apr 2015.
Clinical trials
- A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202521 payments$42,491openpaymentsdata.cms.gov ↗
- Biotest AGProgram year20252 payments
- Janssen Research & Development, LLCProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1999–2003 per NIH RePORTER. The latest:
- SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2003$117,423K08AI001589 - SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2002$117,423K08AI001589 - SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2001$117,423K08AI001589
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
The Journal of Infectious Diseases
2023 - Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
Clinical Infectious Diseases
2023 - Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
Journal of Clinical Investigation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Valerie Rusch, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”